LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 39.64%497.22M | 38.81%401.18M | -33.24%1.37B | -7.17%319.15M | -12.76%410.49M | -42.46%356.07M | -53.84%289.02M | 25.86%2.06B | -32.02%343.79M | -7.13%470.5M |
Operating revenue | 38.47%482.23M | 38.14%388.86M | -33.66%1.34B | -8.33%309.14M | -12.91%401.43M | -42.88%348.25M | -54.03%281.5M | 25.96%2.02B | -32.41%337.25M | -7.61%460.95M |
Cost of revenue | 38.42%462.36M | 38.40%375.6M | -36.37%1.29B | -11.27%298.11M | -16.47%390.64M | -45.31%334.03M | -56.19%271.38M | 28.04%2.03B | -33.42%335.98M | -3.73%467.68M |
Gross profit | 58.21%34.86M | 45.03%25.59M | 216.65%80.57M | 169.70%21.04M | 602.19%19.85M | 173.51%22.03M | 161.00%17.64M | -46.68%25.44M | 597.23%7.8M | -86.43%2.83M |
Operating expense | -16.87%73.51M | 8.95%88.07M | 2.80%393.07M | 100.72%130.88M | -6.48%92.93M | -22.72%88.42M | -21.81%80.83M | 17.05%382.37M | -41.05%65.21M | 6.08%99.36M |
Selling and administrative expenses | -1.71%82.13M | 9.82%87.47M | -5.22%379.88M | 39.09%126.15M | -3.66%90.52M | -21.01%83.56M | -27.83%79.65M | 7.41%400.81M | -16.45%90.7M | -10.58%93.95M |
-Selling and marketing expense | 15.72%56.06M | 27.51%59.35M | -14.31%202.49M | -3.01%50.82M | 3.16%56.69M | -24.50%48.44M | -28.16%46.55M | 6.38%236.31M | -22.74%52.39M | -19.22%54.95M |
-General and administrative expense | -25.75%26.07M | -15.06%28.12M | 7.83%177.39M | 96.66%75.34M | -13.26%33.83M | -15.63%35.12M | -27.37%33.1M | 8.93%164.51M | -5.99%38.31M | 5.28%39M |
Research and development costs | -74.39%2.36M | -61.86%3.38M | -10.30%33.82M | -35.40%6.03M | 2.97%9.71M | -7.64%9.22M | -1.10%8.86M | 4.15%37.7M | 10.56%9.33M | -16.29%9.43M |
Provision for doubtful accounts | 85.80%-162K | --0 | -119.00%-2.63M | -102.74%-359K | -200.46%-435K | -262.07%-1.14M | -84.62%-696K | 2,115.14%13.84M | 443.58%13.08M | -88.26%433K |
Other operating expenses | -236.78%-10.82M | 60.16%-2.78M | 74.28%-18M | 98.05%-935K | -54.07%-6.87M | -57.09%-3.21M | 55.17%-6.99M | 14.66%-69.99M | -445.27%-47.91M | 83.09%-4.46M |
Operating profit | 41.78%-38.65M | 1.12%-62.48M | 12.45%-312.5M | -91.35%-109.84M | 24.30%-73.08M | 37.59%-66.39M | 34.60%-63.19M | -27.96%-356.93M | 47.58%-57.4M | -32.55%-96.54M |
Net non-operating interest income expense | -214.22%-24.09M | -355.20%-22.84M | -202.47%-62.43M | -333.31%-23.96M | -427.39%-25.78M | -51.99%-7.67M | 3.09%-5.02M | 45.05%-20.64M | -6.20%-5.53M | 34.44%-4.89M |
Non-operating interest income | -77.78%10K | -84.31%16K | -71.97%169K | -94.52%8K | -82.28%14K | -58.33%45K | -62.22%102K | -83.52%603K | -37.61%146K | -63.08%79K |
Non-operating interest expense | 212.52%24.1M | 346.45%22.86M | 194.68%62.6M | 322.30%23.97M | 419.28%25.8M | 49.68%7.71M | -6.02%5.12M | -48.47%21.24M | 4.32%5.68M | -35.24%4.97M |
Other net income (expense) | -93.33%1.14M | 200.95%35.53M | -100.14%-322K | 82.40%-2.95M | 3,045.54%20.79M | 210.56%17.04M | -113.44%-35.2M | 33.05%230.43M | -103.53%-16.78M | -99.95%661K |
Gain on sale of security | -83.80%969K | 101.28%479K | -104.27%-10.25M | -18.76%511K | 900.05%20.55M | 150.47%5.98M | -114.95%-37.29M | 35.83%240.28M | -99.87%629K | -99.85%2.06M |
Special income (charges) | --0 | --35.22M | --0 | --0 | --0 | --0 | ---- | ---2.78M | --0 | --0 |
-Less:Other special charges | ---- | ---35.22M | ---- | ---- | ---- | ---- | ---- | --2.78M | --0 | ---- |
Other non- operating income (expenses) | -98.49%167K | -107.97%-167K | 240.54%9.93M | 80.10%-3.46M | 117.29%241K | 1,512.13%11.06M | -83.27%2.1M | -91.05%-7.07M | -4,341.33%-17.41M | -50.70%-1.39M |
Income before tax | -8.04%-61.6M | 51.85%-49.79M | -155.04%-375.25M | -71.56%-136.76M | 22.52%-78.07M | 55.04%-57.02M | -164.56%-103.41M | -2.67%-147.13M | -122.08%-79.72M | -107.87%-100.76M |
Income tax | 0 | -76.97%38K | -15.03%311K | -85.19%12K | -65.79%26K | 86.21%108K | 9.27%165K | 49.39%366K | -63.68%81K | 245.45%76K |
Earnings from equity interest net of tax | --2.43M | ---- | -13,425.00%-5.95M | ---5.95M | --0 | --0 | ---- | -113.41%-44K | --0 | --0 |
Net income | -3.58%-59.17M | 45.60%-49.83M | -169.41%-369.54M | -78.86%-142.72M | 22.55%-78.1M | 50.97%-57.12M | -157.26%-91.6M | 4.23%-137.17M | -122.12%-79.8M | -107.88%-100.84M |
Net income continuous Operations | -3.58%-59.17M | 51.89%-49.83M | -158.58%-381.51M | -78.86%-142.72M | 22.55%-78.1M | 50.97%-57.12M | -164.74%-103.57M | -3.02%-147.54M | -122.12%-79.8M | -107.88%-100.84M |
Net income from tax loss carry forward | --0 | --0 | 15.38%11.97M | --0 | --0 | --0 | --11.97M | --10.37M | --0 | --0 |
Minority interest income | 8,878.95%1.67M | 82,150.00%1.64M | 23,808.33%2.85M | 18,200.00%1.63M | 1.24M | -19K | 33.33%-2K | -12K | -9K | 0 |
Net income attributable to the parent company | -6.54%-60.84M | 43.81%-51.47M | -171.50%-372.39M | -80.92%-144.35M | 21.33%-79.33M | 50.99%-57.11M | -157.26%-91.6M | 4.24%-137.16M | -122.11%-79.79M | -107.88%-100.84M |
Preferred stock dividends | 172.65%2.06B | 1.78B | 278.8M | 755.64M | 0 | |||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 81.89%-60.84M | 43.81%-51.47M | -172.48%-2.43B | -2,313.68%-1.93B | 21.33%-79.33M | -188.30%-335.91M | -157.26%-91.6M | -523.36%-892.79M | -122.11%-79.79M | -107.88%-100.84M |
Basic earnings per share | 99.55%-0.3235 | 98.48%-0.2737 | -68.18%-333 | 43.07%-10.247 | -100.00%-18 | -500.00%-72 | -166.67%-18 | -450.00%-198 | -120.00%-18 | -102.78%-9 |
Diluted earnings per share | 99.55%-0.3235 | 98.48%-0.2737 | -68.18%-333 | 43.07%-10.247 | -100.00%-18 | -500.00%-72 | -166.67%-18 | 68.12%-198 | 33.33%-18 | 50.00%-9 |
Dividend per share | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |